UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Will Korean COVID-19 patients get to use remdesivir for compassionate use?
by Kim Yun-mi
2020-02-24 17:41
Local researchers find new cause of Parkinson’s disease
by Shim Hyun-tai
2020-02-21 18:25
Labor group slams Fresenius for allegedly breaching labor law
by Kim Yun-mi
2020-02-21 16:39
‘Favipiravir not approved as new coronavirus drug yet’
by Kim Yun-mi
2020-02-21 12:08
Theragen Etex marked record-high sales, net profits in 2019
by Lee Han-soo
2020-02-20 18:48
라인
Regulator OKs Pfizer's Vizimpro as 1st-line treatment of mutated lung cancer
by Shim Hyun-tai
2020-02-20 18:47
Daewoong’s Nabota gets item license in Brazil
by Shim Hyun-tai
2020-02-20 16:11
Drugmakers rush to roll out famotidine to replace ranitidine
by Jeong Sae-im
2020-02-18 15:07
Medytox's Meditoxin gets new indication for cervical dystonia
by Shim Hyun-tai
2020-02-18 15:06
JW wins US patent for world’s 1st multi-biomarker diagnostic kit
by Shim Hyun-tai
2020-02-17 17:54
라인
Genexine’s US affiliate gets FDA nod for immune booster trial
by Shim Hyun-tai
2020-02-17 12:46
Helixmith gets mixed results from p3-1 trials of gene therapy
by Shim Hyun-tai
2020-02-14 18:12
Eisai to pull out antiobesity drug Belviq from US market
by Lee Han-soo
2020-02-14 16:38
Daewoong’s sales reached ₩1 trillion milestone in 2019
by Lee Han-soo
2020-02-14 14:33
JW Pharmaceutical turns to loss on reduced sales of nutrients
by Jeong Sae-im
2020-02-14 12:03
라인
Mediforum turned around to net profit in 2019
by Shim Hyun-tai
2020-02-13 17:43
Bukwang's dyskinesia treatment gets FDA nod for p 2 trials
by Shim Hyun-tai
2020-02-13 14:22
Dong-A ST posts robust profit in 2019
by Lee Han-soo
2020-02-13 14:20
ISU’s US partner releases clinical trial results of new hemophilia treatment
by Shim Hyun-tai
2020-02-13 11:18
SK Plasma to enter ME market with self-developed tech
by Shim Hyun-tai
2020-02-12 17:16
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top